PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
Status:
Not yet recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase I Clinical Trial to Evaluate the Tolerability, Safety, Pharmacokinetics and
Preliminary Antitumor Activity of PE0116 and PE0105 Injection in Treatment of Patients with
Advanced Solid Tumor.